Nuzenio

Tradingview Imvt

Tradingview Imvt entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Immunovant, Inc. Stock 12‑Month Price Target Raised to $47.56, Implies 21% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:18 GMT IMVT: Imminent brepocitinib DM launch, robust cash, and major late-stage catalysts ahead - TradingViewTradingView · Thu, 06 Aug 2026 15:05:49 GMT Immunovant, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:01 GMT Immunovant Q1 net loss widens - TradingViewTradingView · Thu, 06 Aug 2026 11:31:22 GMT Roivant Sciences Ltd. 2026: Revenue $1.44M, EPS ($0.26) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:31:03 GMT IMVT: Net loss rose to $153.2M as IMVT-1402 trials expanded; cash reserves at $797.8M - TradingViewTradingView · Thu, 06 Aug 2026 11:30:12 GMT Immunovant reports $153.2M net loss, $797.8M cash as of June 30, 2026 - TradingViewTradingView · Thu, 06 Aug 2026 11:23:02 GMT IMVT: IMVT-1402 clinical development advances on track, with strong cash reserves and rising R&D spend - TradingViewTradingView · Thu, 06 Aug 2026 11:02:04 GMT

Timeline

Thu, 06 Aug 2026 17:20:18 GMTImmunovant, Inc. Stock 12‑Month Price Target Raised to $47.56, Implies 21% Upside - TradingView

Thu, 06 Aug 2026 15:05:49 GMTIMVT: Imminent brepocitinib DM launch, robust cash, and major late-stage catalysts ahead - TradingView

Thu, 06 Aug 2026 13:32:01 GMTImmunovant, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 11:31:22 GMTImmunovant Q1 net loss widens - TradingView

Thu, 06 Aug 2026 11:31:03 GMTRoivant Sciences Ltd. 2026: Revenue $1.44M, EPS ($0.26) — 10-Q Summary - TradingView

Thu, 06 Aug 2026 11:30:12 GMTIMVT: Net loss rose to $153.2M as IMVT-1402 trials expanded; cash reserves at $797.8M - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

IMVT9 live mentions TradingView TradingView5 live mentions Immunovant4 live mentions Inc4 live mentions TradingView Immunovant4 live mentions June4 live mentions EPS4 live mentions Earnings4 live mentions Stock2 live mentions Month Price Target2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Imvt.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.